100% Quality Guarantee
PhD-Level Technical Support
Human CD301/CLEC10A Recombinant Protein (N-His)
Key Features

Human CD301/CLEC10A Recombinant Protein (N-His) (GXRP02540)

SKU GXRP02540
Product Type Recombinant Protein
Species Human
Expression System E. coli
Tag N-His
$458 - $2,412

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CD301/CLEC10A Recombinant Protein (N-His)

Human CD301/CLEC10A Recombinant Protein (N-His) is a recombinant protein expressed in E. coli, spanning Thr71-Met239, with an N-terminal His tag. Predicted molecular weight: 21.29 kDa. Purity: >90% as determined by SDS-PAGE. Supplied lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Applications: ELISA, immunogen, SDS-PAGE and Western blot. C-type lectin domain family 10 member A (CD301/CLEC10A) is a ~35 kDa protein. C-type lectin receptor involved in recognition of N-acetylgalactosamine (GalNAc)-terminated glycans by myeloid antigen presenting cells (APCs). For research use only.

Binds in a Ca(2+)-dependent manner to alpha- and beta-linked GalNAc residues on glycoprotein and glycolipid antigens, including alphaGalNAc- and Galbeta1->3GalNAc-O-Ser/Thr also known as Tn and T antigens, LacdiNAc epitope GalNAcbeta1->4GlcNAc and its derivative GalNAcbeta1->4-(Fucalpha1->3)GlcNAc, O-linked core 5 and 6 glycans, and GM2 and GD2 gangliosides. Acts as a signaling receptor at the interface of APC-T cell interactions. On immature dendritic cells, recognizes Tn antigen-carrying PTPRC/CD45 receptor on effector T cells and downregulates PTRPN/CD45 phosphatase activity with an impact on T cell activation threshold, cytokine production and proliferation. Modulates dendritic cell maturation toward a tolerogenic phenotype leading to generation of regulatory CD4-positive T cell subset with immune suppressive functions. 1. van Vliet, SJ. et al. (2005) International immunology 17, 661-9. PMID: 15802303 2. van Vliet, SJ. et al. (2006) Nature immunology 7, 1200-8. PMID: 16998493 3. van Vliet, SJ. et al. (2007) European journal of immunology 37, 2075-81. PMID: 17616966 4. Li, D. et al. (2012) The Journal of experimental medicine 209, 109-21. PMID: 22213806 5. Gabba, A. et al. (2021) Biochemistry 60, 1327-1336. PMID: 33724805 6. Suzuki, N. et al. (1996) Journal of immunology (Baltimore, Md. : 1950) 156, 128-35. PMID: 8598452 7. Mortezai, N. et al. (2013) Glycobiology 23, 844-52. PMID: 23507963

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose